Cover Image

Impact of SARS‐CoV‐2 infection and COVID‐19 pandemic on the morbidity and mortality of amyotrophic lateral sclerosis patients in Valencia, Spain

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Pilar H. García‐Casanova, Pablo Pérez‐Martínez, Teresa Sevilla, Rosalía Doménech, Montserrat León, Juan F. Vázquez‐Costa
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	European Journal of Neurology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

In Response to “Homogeneous ALS Cohorts in Terms of Etiology, Onset Type and Vaccination Status Are Required to Assess the Outcome of Their COVID Infection”
by: Pilar H. García‐Casanova, et al.
Published: (2025)

Loneliness as neurobehavioral issue in amyotrophic lateral sclerosis
by: Monica Consonni, et al.
Published: (2024)

Rethinking antisense oligonucleotide therapeutics for amyotrophic lateral sclerosis
by: Daisuke Ito, et al.
Published: (2024)

Pattern of paresis in amyotrophic lateral sclerosis: A cohort study
by: Nan Hu, et al.
Published: (2024)

Circulating endocannabinoidome signatures of disease activity in amyotrophic lateral sclerosis
by: Raffaele Dubbioso, et al.
Published: (2024)

Misfolded alpha‐synuclein in amyotrophic lateral sclerosis: Implications for diagnosis and treatment
by: Richard Smith, et al.
Published: (2024)

Croplands proximity is associated with amyotrophic lateral sclerosis incidence and age at onset
by: Umberto Manera, et al.
Published: (2024)

Cervical and thoracic spinal cord gray matter atrophy is associated with disability in patients with amyotrophic lateral sclerosis
by: Maria Janina Wendebourg, et al.
Published: (2024)

Elevated serum circulating cell‐free mitochondrial DNA in amyotrophic lateral sclerosis
by: Jieyu Li, et al.
Published: (2024)

Exploring amyotrophic lateral sclerosis through the visual system: A systematic review
by: Raoul K. Khanna, et al.
Published: (2024)

Reliability study for the Japanese version of the Columbia Muscle Cramp Scale in amyotrophic lateral sclerosis
by: Masahiro Sawada, et al.
Published: (2024)

Brain neurovascular coupling in amyotrophic lateral sclerosis: Correlations with disease progression and cognitive impairment
by: Francesca Trojsi, et al.
Published: (2024)

Fasciculations detected by muscle ultrasonography in the early stage of amyotrophic lateral sclerosis: An autopsy case
by: Hideyuki Moriyoshi, et al.
Published: (2024)

Motor band sign is specific for amyotrophic lateral sclerosis and corresponds to motor symptoms
by: Charlotte Zejlon, et al.
Published: (2024)

Correction to “Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions”
Published: (2025)

Pharmacological and non‐pharmacological treatments in amyotrophic lateral sclerosis: an Italian real‐world data study
by: Olga Paoletti, et al.
Published: (2024)

Sex‐related differences in amyotrophic lateral sclerosis: A 2‐[18F]FDG‐PET study
by: Antonio Canosa, et al.
Published: (2024)

Interaction between riluzole treatment and dietary glycemic index in the disease progression of amyotrophic lateral sclerosis
by: Ikjae Lee, et al.
Published: (2025)

Tracking amyotrophic lateral sclerosis disease progression using passively collected smartphone sensor data
by: Marta Karas, et al.
Published: (2024)

Association of APOE genotype and cerebrospinal fluid Aβ and tau biomarkers with cognitive and motor phenotype in amyotrophic lateral sclerosis
by: Alessio Maranzano, et al.
Published: (2024)

Distinct neural signatures of pulvinar in C9orf72 amyotrophic lateral sclerosis mutation carriers and noncarriers
by: Anna Nigri, et al.
Published: (2024)

Connectivity‐based striatal subregion microstructural changes in sporadic amyotrophic lateral sclerosis patients: Relation to motor disability, cognitive deficits, and serum biomarkers
by: Yujing Chen, et al.
Published: (2024)

In‐depth analysis of data from the RAS‐ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosis
by: Joachim Schuster, et al.
Published: (2024)

Cerebrospinal fluid and blood neurofilament light chain levels in amyotrophic lateral sclerosis and frontotemporal degeneration: A meta‐analysis
by: Federico Verde, et al.
Published: (2024)

European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERNEURO‐NMD)
by: Philip Van Damme, et al.
Published: (2024)

Ofatumumab treatment in new‐onset narcolepsy type 1 following SARS‐CoV‐2 infection
by: Xiaoli Wang, et al.
Published: (2024)

Longitudinal study of immunity to SARS‐CoV2 in ocrelizumab‐treated MS patients up to 2 years after COVID ‐19 vaccination
by: Ilya Kister, et al.
Published: (2024)

Reply to the letter: Headaches during/after SARS‐CoV‐2 infection/vaccination can be primary and secondary as well as acute and chronic, by Finsterer J and Mehri S
by: Dimos‐Dimtirios D. Mitsikostas, et al.
Published: (2024)

Increased risk of functional neurological disorders following SARS‐CoV‐2 vaccination
by: Andrea Pilotto, et al.
Published: (2024)

SARS‐CoV‐2 Is Linked to Brain Volume Loss in Multiple Sclerosis
by: Tomas Uher, et al.
Published: (2025)

Clinical and neuroimaging characteristics of primary lateral sclerosis with overlapping features of progressive supranuclear palsy
by: Negin Badihian, et al.
Published: (2024)

Stable excess mortality in a multiple sclerosis cohort diagnosed 1970–2010
by: M.‐L. Sumelahti, et al.
Published: (2024)

Long‐Term Persistent Headache After SARS‐CoV‐2 Infection: A Follow‐Up Population‐Based Study
by: Lénia Silva, et al.
Published: (2025)

Patient‐reported daily functioning after SARS‐CoV‐2 vaccinations in autoimmune neuromuscular diseases
by: Koos P. J. van Dam, et al.
Published: (2024)

Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis
by: Jens Ingvarsson, et al.
Published: (2024)

New‐Onset Headache After SARS ‐ CoV ‐2 Infection and Vaccination: Results From Three Population‐Based Cohorts in Norway
by: Kristine Blix, et al.
Published: (2025)

Diagnostic Yield and Genotype–Phenotype Correlations of Clinical Exome Sequencing in Hereditary Spastic Paraparesis: Experience From Eastern Spain
by: Lidón Carretero‐Vilarroig, et al.
Published: (2026)

The influence of menopause on multiple sclerosis
by: Cecilia Smith Simonsen, et al.
Published: (2024)

Clinical effectiveness of coronavirus disease 2019 vaccination in patients with multiple sclerosis stratified by disease‐modifying treatment
by: Marijke De Troyer, et al.
Published: (2024)

Neurological complications in patients with SARS-CoV-2 infection: a systematic review
by: Munhoz, Renato Puppi, et al.
Published: (2020)